Not applicableUnknownNCT01590498What this trial is testingRadiotherapy vs Observation for CRPCWho this might be right forHormone Refractory Prostate Cancer Zhengzhou University 2,000
Testing effectiveness (Phase 2)Study completedNCT01519414What this trial is testingTivantinib in Treating Patients With Metastatic Prostate CancerWho this might be right forHormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more National Cancer Institute (NCI) 78
Early research (Phase 1)Active Not RecruitingNCT06193993What this trial is testingEffect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer PatientsWho this might be right forProstate CancerMetastatic CancerHormone Sensitive Prostate Cancer+1 more National University Hospital, Singapore 10
Testing effectiveness (Phase 2)Looking for participantsNCT07288359What this trial is testingStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsWho this might be right forAdvanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer Novartis Pharmaceuticals 205
Testing effectiveness (Phase 2)Ended earlyNCT01313559What this trial is testingPasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate CancerWho this might be right forCastrate Resistant Prostate CancerChemotherapy Naive Prostate CancerProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 6
Testing effectiveness (Phase 2)Study completedNCT01741116What this trial is testingDovitinib(TKI258) in Patients With Castration-resistant Prostate CancerWho this might be right forHormone Refractory Prostate Cancer Korean Cancer Study Group 44
Early research (Phase 1)Looking for participantsNCT06801236What this trial is testingPhase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer) Acerand Therapeutics (Hong Kong) Limited 88
Very early researchStudy completedNCT02113657What this trial is testingT-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstate Cancer M.D. Anderson Cancer Center 30
Not applicableUnknownNCT03979339What this trial is testingFeasibility of a New Technology for Isolating Circulating Tumour CellsWho this might be right forHER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more Centre Oscar Lambret 76
Testing effectiveness (Phase 2)Ended earlyNCT03330405What this trial is testingJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsWho this might be right forAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors Pfizer 223
Testing effectiveness (Phase 2)Study completedNCT01807065What this trial is testingSipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate CancerWho this might be right forAdenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate Cancer+3 more City of Hope Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT00973882What this trial is testingCarboplatin-Etoposide Combination in Hormone-Resistant Prostate CancersWho this might be right forProstate Cancer Centre Leon Berard 60
Testing effectiveness (Phase 2)UnknownNCT02691975What this trial is testingA Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer PatientsWho this might be right forHormone Refractory Prostate CancerMetastatic Prostate Carcinoma Jiangsu HengRui Medicine Co., Ltd. 197
Testing effectiveness (Phase 2)Ended earlyNCT00104130What this trial is testingStudy of KOS-862 (Epothilone D) in Metastatic Prostate CancerWho this might be right forProstate Cancer Bristol-Myers Squibb 53
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557What this trial is testingPembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideWho this might be right forCastration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more OHSU Knight Cancer Institute 58
Testing effectiveness (Phase 2)Study completedNCT00436956What this trial is testingAZD2171 to Treat Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 59
Not applicableStudy completedNCT01833208What this trial is testingRadiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-TWho this might be right forHormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more Roswell Park Cancer Institute 15
Not applicableStudy completedNCT01160705What this trial is testingBiomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2Who this might be right forMetastatic CancerProstate Cancer Cancer Trials Ireland 73
Large-scale testing (Phase 3)Looking for participantsNCT03903835What this trial is testingProBio: A Biomarker Driven Study in Patients With Metastatic Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Karolinska Institutet 750